Saniona Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Saniona
Access all reports
Saniona AB is a clinical-stage biopharmaceutical company based in Denmark, focused on the discovery and development of treatments for central nervous system, autoimmune, metabolic diseases, and pain management. The company specializes in modulating ion channels, a class of proteins critical in cellular signaling. Saniona has built a proprietary drug discovery platform that includes more than 20,000 ion channel-modulating molecules. The company is headquartered in Ballerup, Denmark, and its shares are listed on the Nasdaq Stockholm.
Latest articles
House of Pinault: The History and Business of Kering and Gucci
Kering is a luxury group under the Pinault family's leadership, managing iconic brands like Gucci, Saint Laurent, and Bottega Veneta.
19 Dec 2024
Under the Hood: AutoZone's Blueprint for Retail Excellence
An in-depth look at the largest aftermarket auto parts retailer in the U.S., its philosophy, and masterful capital allocation.
19 Dec 2024
Lessons from Gautam Baid: Mastering Simplicity and Compounding
Gautam Baid's journey of compounding wisdom, investing simplicity, and lifelong learning – insights to transform your financial and personal growth.
13 Dec 2024
Ticker symbol
SANION
Country
🇸🇪 Sweden